Acinetobacter baumannii is a bacterial infection that is causing concern in the medical community due to its resistance to many antibiotics. It is one of the biggest challenges in modern medicine, as this bacterium can cause serious illness, especially in patients with weakened immune systems. However, recent research has shown that there is hope for eradicating it through phage therapy—a method that uses bacteriophages to combat pathogens.

Basic information about bacteria

Acinetobacter baumannii is a gram-negative bacterium commonly found in hospital settings. This bacterium can survive on medical instruments and surfaces for long periods of time, facilitating its spread in hospitals.

The main routes of infection with Acinetobacter baumannii are through contaminated medical instruments or direct contact with infected individuals. It can enter the body through wounds, catheters, or other medical devices. Therefore, hospitalized patients and those with chronic illnesses are at increased risk.

How Antibiotic Resistance Is Making Acinetobacter Baumannii Even More Dangerous

The bacterium Acinetobacter baumannii has become one of the main causes of the global problem of antibiotic resistance. In particular, many of its strains can become resistant to carbapenems, a class of antibiotics typically used as a last resort for the treatment of severe infections. As antibiotic resistance develops, more and more Acinetobacter baumannii strains emerge that are untreatable with standard antibiotics, reducing the chances of successful recovery for patients.

Symptoms and diseases caused by Acinetobacter baumannii

Infections caused by Acinetobacter baumannii can present differently depending on which organs and systems the bacteria affect. Some of the most common infections associated with this bacterium include:

• Pneumonia , especially in patients on ventilators. Symptoms include high fever, chest pain, cough, and shortness of breath.

• Urinary tract infections , which cause pain when urinating, frequent urination, and even blood in the urine.

• Wound infections are particularly severe infections following surgery or injury that can cause prolonged healing or purulent lesions.

• Sepsis is a serious systemic inflammation that can be life-threatening.

Phages and Science vs. Acinetobacter baumannii

Recent scientific studies show that phage therapy has great potential in the treatment of infections caused by Acinetobacter baumannii.

1. Bacteriophages restore bacteria's sensitivity to antibiotics: Researchers from Monash University in Melbourne studied the effects of bacteriophages on antibiotic-resistant strains of A. baumannii. They found that some strains became resistant to phages due to mutations that deprived the bacteria of their surface capsule—the primary site of viral attachment. ( bacteriophages.info )

2. Bacteriophages in the treatment of bacterial osteomyelitis: Israeli doctors described a clinical case of treating a patient with a tibia infection caused by an extremely resistant strain of A. baumannii and a multidrug-resistant strain of Klebsiella pneumoniae. The combination of bacteriophages and antibiotics resulted in rapid eradication of the bacteria and wound healing, preventing amputation. ( bacteriophages.info )

3. Phages are effective against ESCAPE bacteria: A systematic review of studies has found that phage therapy is effective and safe for treating infections caused by ESCAPE bacteria, which includes A. baumannii. ( bacteriophages.info )

4. "The Perfect Predator": A book about how bacteriophages save lives, featuring a real-life case of bacteriophages saving the life of a patient with a multidrug-resistant A. baumannii infection. This highlights the potential of phage therapy in the fight against drug-resistant bacteria. ( bacteriophages.info )

5. Bacteriophages against biofilms in chronic wounds: A study showed that phages effectively destroy biofilms formed by multidrug-resistant strains of A. baumannii, Pseudomonas aeruginosa, Proteus mirabilis, and Escherichia coli in chronic wound models. ( bacteriophages.info )

6. The first phage therapy center has opened in the United States: This article describes the opening of the first phage therapy center in the United States, IPATH, in San Diego. The initiative arose after the successful treatment of a patient with an A. baumannii infection, which is resistant to all available antibiotics. ( bacteriophages.info )

Acinetobacter baumannii is one of the most dangerous bacteria in the world today, particularly due to its resistance to antimicrobials. However, phage therapy offers new hope in the fight against this bacterium. Using bacteriophages to treat infections caused by Acinetobacter baumannii could be an important step toward overcoming the global antibiotic resistance crisis.